• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000263
Device Problem Failure to Advance (2524)
Patient Problem Death (1802)
Event Date 12/16/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Other remarks: see mdr# 3010532612-2021-00005 ((b)(4)) as the report is related to the same patient.
 
Event Description
It was reported that during insertion, the guide wire was not passing through the central lumen of the intra-aortic balloon (iab), as the staff stated that "there was an obstruction".As a result, another iab was used.There was a report of patient death.Dr.(b)(6) made the medical judgement that the device did not cause or contribute to patient's d eath.
 
Event Description
It was reported that during insertion, the guide wire was not passing through the central lumen of the intra-aortic balloon (iab), as the staff stated that "there was an obstruction".As a result, another iab was used.There was a report of patient death.Dr.(b)(6) the medical judgement that the device did not cause or contribute to patient's d eath.
 
Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint of iab tight over guidewire is confirmed.During the investigation, there was immediate resistance noted upon passing the guidewire through the iabc central lumen.The guidewire insertion difficulty was occurring within the bifurcate.Additionally, a cross-over leak was confirmed between the helium pathway and central lumen, however there was no obvious central lumen break and the crossover site potentially occurred within the bifurcate.A non-conformance has been initiated to further investigate the issue.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.Other remarks: see mdr# 3010532612-2021-00005 (b)(4)) as the report is related to the same patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key11202228
MDR Text Key227947983
Report Number3010532612-2021-00006
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902002679
UDI-Public00801902002679
Combination Product (y/n)N
PMA/PMN Number
K981660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2022
Device Model NumberIPN000263
Device Catalogue NumberIAB-S840C
Device Lot Number18F20B0045
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/08/2021
Date Manufacturer Received03/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age57 YR
-
-